Most youth with type 1 diabetes don't meet HbA1c goals

Most youth with type 1 diabetes don't meet HbA1c goals
Most children with type 1 diabetes have hemoglobin A1c values above target levels, according to a study published online Jan. 22 in Diabetes Care.

(HealthDay)—Most children with type 1 diabetes (T1D) have hemoglobin A1c (HbA1c) values above target levels, according to a study published online Jan. 22 in Diabetes Care.

Jamie R. Wood, M.D., from the Children's Hospital Los Angeles, and colleagues assessed the proportion of youth meeting targets for HbA1c, blood pressure, and (BMI) using data from 13,316 participants in the T1D Exchange Clinic Registry younger than 20 years old with type 1 diabetes for at least one year.

The researchers found that 64, 43, and 21 percent of participants met the HbA1c targets of <8.5 percent for those younger than 6 years, <8.0 percent for those age 6 to younger than 13 years old, and <7.5 percent for those age 13 to younger than 20 years old, respectively. Most participants met the blood pressure and lipid targets, and two-thirds met the goal of <85th percentile for BMI.

"Despite advances in technologies and strategies for care, achieving HbA1c targets remains a significant challenge for the majority of youth in the T1D Exchange registry. Moreover, a large number of youth with diabetes already have additional vascular disease risk factors at a young age," the authors write. "This analysis suggests further transformations to improve pediatric are needed to prevent future complications of diabetes."

One author disclosed receiving consultant payments from Medtronic.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

Roux-en-Y surgery can reverse insulin treatment in T2DM

Jan 21, 2015

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study ...

Unexpected turn in diabetes research

Jan 20, 2015

Years of diabetes research carried out on mice whose DNA had been altered with a human growth hormone gene is now ripe for reinterpretation after a new study by researchers at KU Leuven confirms that the gene had an unintended ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.